A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Condition(s):Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV; Squamous Non-small-cell Lung Cancer; Large Cell Carcinoma Lung; Adenocarcinoma LungLast Updated:January 25, 2024Active, not recruiting